Cidnavir Injection

Cidnavir Injection is an antiviral drug belonging to the purine nucleoside category, containing the active ingredient Cidofovir. It is used to treat Cytomegalovirus (CMV) retinitis in patients with AIDS, a serious opportunistic infection that can develop in individuals with AIDS. The infection affects the retina of the eye and may lead to vision impairment if untreated. Inform your physician immediately if you experience allergies to this drug or its ingredients. If you develop pain, redness, itching of the eye, or changes in your vision, notify your doctor promptly. Use this drug with caution if you have diabetes mellitus, as there may be an increased risk of developing low eye pressure (ocular hypotony). Regular testing of your eyes and blood counts will be necessary. Discuss contraceptive options with your doctor before starting this treatment if there is a possibility you may become pregnant. Women should use reliable birth control during treatment and for at least six months after the last dose. Avoid breastfeeding while on this medicine, as it is unknown whether Cidnavir Injection passes into breast milk. Inform your doctor of any other medications you take before using over-the-counter or herbal products, as your doctor will evaluate the risk of interaction with this medication.

Treatment of Cytomegalovirus (CMV) Infections Prevention of CMV Retinitis Management of CMV Infections in Transplant Patients Treatment of Severe Viral Infections Adjunct Therapy in Immunocompromised Conditions

Cidnavir Injection is an antiviral medication primarily used to treat and prevent cytomegalovirus (CMV) infections, especially in immunocompromised individuals such as organ transplant recipients and patients with HIV/AIDS. It works by inhibiting the replication of the virus, reducing the viral load, and preventing disease progression. By effectively controlling CMV, Cidnavir Injection helps lower the risk of complications such as CMV retinitis, which can lead to vision loss and systemic infections that may affect multiple organs. Its therapeutic effects contribute to better overall health outcomes in high-risk patients by reducing the severity and recurrence of CMV-related conditions.

Cidnavir Injection should be administered under the supervision of a healthcare professional. It is given as an intravenous (IV) infusion over a specific duration, as prescribed by the doctor. The dosage and frequency depend on the patient's medical condition, kidney function, and response to treatment. Adequate hydration before and after administration is recommended to minimize the risk of kidney toxicity. It is essential to follow the healthcare provider’s instructions carefully and not to self-administer the injection.

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious Kidney damage Common Nausea, vomiting Headache Hair loss Weakness Fever, chills Difficulty in breathing Diarrhea Inflammation of the eye, reduced pressure in the eyes

Drink plenty of water with this antiviral medicine, which helps prevent dehydration and kidney damage. While receiving Cidnavir injection and for three months afterward, males should use (condom) barrier birth control techniques. Sodium is present in this drug. If you follow a salt-restricted diet, seek a physician's guidance.